Pfizer, Inc. Press Releases

PFE 
$36.11
*  
0.04
0.11%
Get PFE Alerts
*Delayed - data as of Aug. 4, 2015  -  Find a broker to begin trading PFE now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    PFE Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Pfizer Receives Approval From European Commission For Pending Acquisition Of Hospira
8/4/2015 11:36:00 AM - Business Wire
▲0.33 % Price Change since this news event. The Volume Ratio is 1.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
8/3/2015 8:30:00 AM - Business Wire
▲0.31 % Price Change since this news event. The Volume Ratio is 0.7.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Hospira Reports Second-Quarter 2015 Results
7/29/2015 7:30:00 AM - PR Newswire


PFIZER REPORTS SECOND-QUARTER 2015 RESULTS
7/28/2015 7:00:00 AM - Business Wire
▲3.20 % Price Change since this news event. The Volume Ratio is 4.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility
7/22/2015 8:30:00 AM - Business Wire
▲3.05 % Price Change since this news event. The Volume Ratio is 1.14.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


America''s Most-Preferred Bone Health Brand Launches New Caltrate® Bone & Joint Health Supplement
7/21/2015 8:00:00 AM - Business Wire
▲2.18 % Price Change since this news event. The Volume Ratio is 1.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Watch List for Drug Manufacturers - Major Equities -- Pfizer, Bristol-Myers Squibb, Eli Lilly, Kythera Biopharma, and Impax Laboratories
7/20/2015 9:25:00 AM - PR Newswire
▲2.88 % Price Change since this news event. The Volume Ratio is 0.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer’s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunological Research
7/8/2015 8:30:00 AM - Business Wire
▲7.57 % Price Change since this news event. The Volume Ratio is 0.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Nodality, Inc. Appoints Kathleen LaPorte as Chief Executive Officer
7/8/2015 8:00:00 AM - Business Wire
▲7.57 % Price Change since this news event. The Volume Ratio is 0.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Elective Spinal Fusion Surgery
7/7/2015 8:00:00 AM - Business Wire
▲8.11 % Price Change since this news event. The Volume Ratio is 1.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib citrate) Modified Release Tablets
7/2/2015 4:30:00 PM - Business Wire
▲8.21 % Price Change since this news event. The Volume Ratio is 1.15.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D
7/2/2015 9:30:00 AM - PR Newswire
▲6.49 % Price Change since this news event. The Volume Ratio is 1.71.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Joseph J. Echevarria Elected To Pfizer’s Board Of Directors
6/25/2015 11:20:00 AM - Business Wire
▲5.40 % Price Change since this news event. The Volume Ratio is 2.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Declares 28-Cent Third-Quarter 2015 Dividend
6/25/2015 11:15:00 AM - Business Wire
▲5.31 % Price Change since this news event. The Volume Ratio is 2.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination including TRUMENBA® for Adolescents and Young Adults 16 through 23 Years of Age
6/24/2015 1:19:00 PM - Business Wire
▲5.28 % Price Change since this news event. The Volume Ratio is 3.02.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Pfizer Invites Public To View And Listen To Webcast Of July 28 Conference Call With Analysts
6/23/2015 10:00:00 AM - Business Wire
▲4.42 % Price Change since this news event. The Volume Ratio is 0.99.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


New Online Community, Quitter’s Circle, Helps Smokers Trade Cigarettes for Real-Time Support
6/23/2015 8:00:00 AM - Business Wire
▲5.28 % Price Change since this news event. The Volume Ratio is 0.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline
6/22/2015 7:00:00 AM - Business Wire
▲5.71 % Price Change since this news event. The Volume Ratio is 0.75.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Consumer Healthcare To Expand Caltrate And Centrum Production In China
6/15/2015 8:00:00 AM - Business Wire
▲5.71 % Price Change since this news event. The Volume Ratio is 1.31.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder
6/11/2015 3:00:00 PM - Business Wire
▲4.55 % Price Change since this news event. The Volume Ratio is 2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Builds Upon Robust Body Of Knowledge For XELJANZ® (tofacitinib citrate) With Clinical Trial And Real-World Use Data At The European League Against Rheumatism Annual Congress (EULAR 2015)
6/10/2015 8:00:00 AM - Business Wire
▲6.14 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day